BRIEF published on 05/17/2024 at 15:05, 6 months 3 days ago Protenus reconnu pour l'excellence en milieu de travail en 2024 Protenus Analyse Des Soins De Santé La Satisfaction Des Employés Excellence Du Lieu De Travail Certification Great Place To Work
BRIEF published on 05/17/2024 at 15:05, 6 months 3 days ago Protenus Recognized for Workplace Excellence in 2024 Employee Satisfaction Protenus Healthcare Analytics Workplace Excellence Great Place To Work Certification
PRESS RELEASE published on 05/17/2024 at 15:00, 6 months 3 days ago Protenus Earns Esteemed Workplace Honors for 2024 Protenus recognized as one of the 2024 Modern Healthcare Best Places to Work in Healthcare and a Great Place to Work® for the fifth year, highlighting commitment to employee well-being and workplace culture Healthcare Compliance Work-life Balance Protenus Great Place To Work® Employee-centric Culture
BRIEF published on 04/04/2024 at 16:05, 7 months 16 days ago Protenus remporte un accord de solutions logicielles de détournement de médicaments avec Premier, Inc. Protenus Conformité Des Soins De Santé Premier Inc. Prévention Du Détournement De Drogues Technologie De Surveillance
BRIEF published on 04/04/2024 at 16:05, 7 months 16 days ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Healthcare Compliance Protenus Premier Inc. Drug Diversion Prevention Surveillance Technology
PRESS RELEASE published on 04/04/2024 at 16:00, 7 months 16 days ago Protenus Awarded Drug Diversion Software Solutions Agreement With Premier, Inc. Protenus awarded national group purchasing agreement with Premier, Inc. for Drug Diversion Software Solutions, offering Premier members special pricing and terms for Protenus solution Healthcare Protenus Premier Inc. Drug Diversion Supplier Contract
BRIEF published on 04/02/2024 at 16:05, 7 months 18 days ago Protenus Secures Two Innovative Patents for Enhancing Healthcare Compliance Healthcare Compliance Protenus Patient Privacy Monitoring Technology Innovation U.S. Patents
BRIEF published on 04/02/2024 at 16:05, 7 months 18 days ago Protenus obtient deux brevets innovants pour améliorer la conformité des soins de santé Innovation Technologique Protenus Conformité Des Soins De Santé Surveillance De La Confidentialité Des Patients Brevets Américains
PRESS RELEASE published on 04/02/2024 at 16:00, 7 months 18 days ago Protenus Granted Two New Patents for Healthcare Compliance Protenus expands patient privacy monitoring technology with new patents to help hospitals identify record breaches. CEO emphasizes AI-driven solutions for protecting patient data Protenus Healthcare Compliance Analytics Patient Privacy Monitoring New Patents Data Breach
BRIEF published on 03/26/2024 at 16:05, 7 months 25 days ago Protenus Granted Sixth Patent for Drug Diversion Surveillance Technology Artificial Intelligence Healthcare Compliance Protenus Drug Diversion Surveillance Patent Grant
Published on 11/21/2024 at 11:30, 12 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 39 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 42 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 42 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 7 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 11:30, 12 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 41 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 42 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 45 minutes ago ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 12 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 06:58, 4 hours 44 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 44 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 44 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 35 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 22 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting